Archive | clinical trial resources RSS for this section

Want to celebrate Clinical Trials Day (May 20), but don’t know what to do? Read here to download a printable poster and videos from N2 and ItStartsWithMe.ca. Share at your site or on social media

  • Print out the poster below by clicking here and post it at your site this week to engage and inform patients and the public about why we celebrate Clinical Trials Day.
  • Share the “It Starts With Me” video about clinical trials through e-mail and social media, or play it on televisions in waiting rooms. This brief, 1-minute video gives individuals an overview of the potential benefits of clinical trials and information on how they can get involved. You can see the video in English here and in French here.
  • Join our “Ask Me” campaign by contacting Dawn Richards, our Business Development Specialist, at dawn.richards@n2canada.ca, and create dialogue at your site around clinical trials and how to get involved.

Happy Clinical Trials Day, and a huge thank you to all clinical research professionals for your contributions to public health and medical progress!

SAVE-THE-DATE: C17 “Next Generation of Early Phase Trials: Moving the Bar in Pediatric Oncology” educational workshop (Saturday, 4 November 2017)

C17 “Next Generation of Early Phase Trials: Moving the Bar in Pediatric Oncology educational workshop being held on Saturday, 4 November 2017 in Vancouver, BC. The workshop is in response to the C17 DVL needs assessment that was completed last year as we expanded the C17 DVL network across Canada from 8 to 11 sites. While many investigators and research staff have had experience or education in early phase trials, here was a need identified to provide education and mentorship to research staff conducting early phase trials. With the development of pediatric precision medicine trials in Canada, the need will be even greater.

The workshop is a full day, pre-session workshop at the CCRA Canadian Cancer Research Conference. We hope that most attendees at our workshop will take the opportunity to attend the full conference as well.

The workshop will be designed to educate investigators on traditional models of early phase trials as well as newer approaches to drug development. We will also cover regulatory, ethical, advocacy and access aspects of early phase trials. The workshop will proved education, discussions, panels and time for questions.

Our goal will be to help provide some funding to C17 DVL participating centres to allow investigators and senior research staff to attend.

 

More details will be circulated once available.

 

Did you know that 27 pediatric oncology studies have been added to the 3CTN portfolio since April 2014? Follow the weekly C17 Sosido Digest for our new study focus postings, like the one below.

Each pediatric hem/onc site is sent a reporting worksheet every three months.  This sheet shows all 3CTN eligible pediatric studies, or you can search the 3CTN Portfolio Directly at:  http://portfolio.3ctn.ca/

If you notice a study missing from the portfolio, please contact us.  The eligibility criteria are:

  • a cancer intervention clinical trial
  • an academic clinical trial (if a NOL is required, a non-industry organization/institute must be sponsor)
  • open at more that one Canadian site – note that the second site can be an adult oncology program

 

Release of CCTCC REB Accreditation WG Final Recommendations & Joint Response by CCTCC & Health Canada

The purpose of this message is to introduce the CCTCC REB Accreditation WG’s Final Recommendations (FRs), and the joint response by the CCTCC and Health Canada (HC) to the FRs.
The full package is available HERE.

CCTCC REB WG FRs:

There are seven FRs in total, aimed at ensuring Canada’s REB competitiveness on a global scale. FR#7, which calls for the establishment of a National Strategic Leadership Forum, is seen as the foundation of the other FRs. The FRs are based on data collected through interviews with key stakeholders in the Canadian and US REB fields as well as consultations and feedback provided by key REB stakeholders in Canada.

Background:

The CCTCC REB Accreditation WG was established in 2015, in collaboration with Health Canada, to identify strategies to improve efficiencies of ethics reviews and advance strategic issues like accreditation in regards to clinical trials. The establishment of the WG is consistent with Recommendation #4 of the Action Plant to Help Attract More Clinical Trials to Canada as well as Recommendation #3 of the Senate Report entitled “Canada’s Clinical Trials Infrastructure: A prescription for Improved Access to New Medicines”.

Given the REB centralization and harmonization initiatives that have been taking place across Canada, the WG, as stated in their Interim Report (IR), did not see formal accreditation scheme as a given. The IR’s key recommendations called for investigating the:

  • impact of these provincial initiatives
  • models of review being adopted by these initiatives,
  • standards and metrics currently being applied to REB operations (in Canada and USA)

The WG proceed with addressing the IR’s recommendations which resulted in the presented/attached FRs.

The contents of the full package include:

  1. Summary of the FRs and joint response by CCTCC and HC
  2. Full text of the FRs
  3. SPOR SHRER Report Committee recommendations – in fulfillment of FR I

CCTCC and Health Canada wish to express their profound gratitude to the members of the REB Accreditation Working Group (WG) and specifically the chair of the WG – Laurel Evans and the co-chair Karine Morine for their continued dedication and invaluable efforts in making the attached report a reality.

Please direct any questions to Elena Aminkova, Interim Director of Project Facilitation, CCTCC by emailing eaminkova@cctcc.ca

New Agents & Innovative Therapy Program December newsletter is available now

The December 2016 NAIT newsletter can be found HERE.

BOOKMARK NAIT:  The current list of all open trials can be found on the NAIT Website at www.sickkids.ca/HaematologyOncology/nait/index.html

HELPING FAMILIES NAVIGATE:  To assist patients and families with their transition, our Patient Navigator Program will collaborate with your team and the family to provide assistance with issues related to travel, accommodation, and navigating their way around the hospital and in the city. Furthermore, for patients living outside of Ontario, our Patient Navigator will assist physicians in completing an Out-of-Province Prior Approval Application to the Provincial Ministry of Health.

The vision of the New Agents and Innovative Therapy Program (NAIT) supports The Garron Cancer Centre and SickKids’ commitment to innovation and providing Canadian children and their families living with cancer with greater access to the best and newest treatment that will assist to improve clinical care.

New Agents & Innovative Therapy Program November newsletter is available now

The November 2016 NAIT newsletter can be found HERE.

BOOKMARK NAIT:  The current list of all open trials can be found on the NAIT Website at www.sickkids.ca/HaematologyOncology/nait/index.html

HELPING FAMILIES NAVIGATE:  To assist patients and families with their transition, our Patient Navigator Program will collaborate with your team and the family to provide assistance with issues related to travel, accommodation, and navigating their way around the hospital and in the city. Furthermore, for patients living outside of Ontario, our Patient Navigator will assist physicians in completing an Out-of-Province Prior Approval Application to the Provincial Ministry of Health.

The vision of the New Agents and Innovative Therapy Program (NAIT) supports The Garron Cancer Centre and SickKids’ commitment to innovation and providing Canadian children and their families living with cancer with greater access to the best and newest treatment that will assist to improve clinical care.

New Agents & Innovative Therapy Program October newsletter is available now

The October 2016 NAIT newsletter can be found HERE..

 

BOOKMARK NAIT:  The current list of all open trials can be found on the NAIT Website athttps://www.sickkids.ca/HaematologyOncology/nait/index.html

HELPING FAMILIES NAVIGATE:  To assist patients and families with their transition, our Patient Navigator Program will collaborate with your team and the family to provide assistance with issues related to travel, accommodation, and navigating their way around the hospital and in the city. Furthermore, for patients living outside of Ontario, our Patient Navigator will assist physicians in completing an Out-of-Province Prior Approval Application to the Provincial Ministry of Health.

The vision of the New Agents and Innovative Therapy Program (NAIT) supports The Garron Cancer Centre and SickKids’ commitment to innovation and providing Canadian children and their families living with cancer with greater access to the best and newest treatment that will assist to improve clinical care.

ACRP Announces Unrestricted Public Access to ‘Introduction to Clinical Trials’ Training Program. Suitable for staff (1.0 CBRN, ACCME), students and families.

Free Program to Help Develop Competence in Clinical Research Workforce and Raise Awareness of Clinical Trials

Washington, DC – The Association of Clinical Research Professionals (ACRP) announced immediate availability of a free educational program, “Introduction to Clinical Trials.”

Introduced at DIA 2016 in Philadelphia, PA, last month, Introduction to Clinical Trials provides fundamental education about the role clinical research plays in advancing medical knowledge and the work conducted by clinical research professionals.

The course details how medical products are developed, how volunteer patients are protected, and who plays key roles in the development, research, review, and approval of medical products. The one-hour online program also explores how historical studies have laid the path for creation, revision, and enforcement of the ethical principles and guidelines governing today’s clinical trials.

“ACRP is proud to offer this fundamental education in support of our mission to promote excellence in clinical research,” says Jim Kremidas, ACRP Executive Director. “As the leader in clinical research workforce development, providing those new to the profession with a core understanding of clinical research is a critical initiative for ACRP. We are thrilled to be able to freely provide this program to individuals, clinical trial sites, contract research organizations, and trial sponsors and suppliers. Thank you to Labconnect LLC for providing ACRP the educational grant to develop this program.”

Introduction to Clinical Trials is an ideal program for novice clinical researchers, including investigators, coordinators, and trial monitors, to develop the foundational knowledge upon which they can develop their competence as clinical research professionals. The program is also perfect for those interested in the profession or indirectly involved in clinical trials.

Introduction to Clinical Research is immediately available for free individual use through ACRP’s Learning Management System (LMS) here. The SCORM-compliant program can also be hosted on organizational Learning Management Systems. Contact Jenna Rouse, ACRP Director of Business Development, at jrouse@acrpnet.org or +1.703.254.8109 for information.

In addition to supporting clinical research professionals and organizations, this program is an ideal tool for organizations seeking to help educate the public about clinical research and to raise awareness of clinical trials and the clinical research profession.

“We welcome everyone looking to spread the word about clinical research to leverage this resource, including the academic institutions and other associations around the world educating those who will ultimately become the workforce of tomorrow,” says Kremidas.

Introduction to Clinical Trials is accredited by the Accreditation Council for Continuing Medical Education to provide 1 Continuing Medical Education credit for physicians, and by the California Board of Registered Nursing to provide 1 contact hour of continuing nursing education credit.

Continuing Nursing Education

The California Board of Registered Nursing approves the Association of Clinical Research Professionals (ACRP) as a provider of continuing nursing education. This live activity provides 1.0 contact hours of continuing Nursing education credit (Program Number 11147-2016-ICR-100).

Accreditation Council for Continuing Medical Education

The Association of Clinical Research Professionals (ACRP) is accredited by the Accreditation Council for Continuing Medical Education to provide Continuing Medical Education for physicians.

The Association of Clinical Research Professionals designates this live activity for a maximum of 1.0 AMA PRA Category 1 credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity.
CME Program Number: 0007229-2016-ICR-100

ACCME Physician Attributes

  • Work in interdisciplinary teams – cooperate, collaborate, communicate, and integrate care in teams to ensure that care is continuous and reliable
  • Apply quality improvement – identify errors and hazards in care; understand and implement basic safety design principles, such as standardization and simplification; continually understand and measure quality of care in terms of structure, process, and outcomes in relation to patient and community needs; and design and test interventions to change processes and systems of care, with the objective of improving quality
  • Employ evidence-based practice – integrate best research with clinical expertise and patient values for optimum care, and participate in learning and research activities to the extent feasible

Subject Matter Expert Developers

  • Eric Hayashi, President & CEO, Labconnect, LLC
  • James Chrisman, Labconnect, LLC

About ACRP

ACRP supports clinical research professionals through membership, training and development, and certification. Founded in 1976, ACRP is a Washington, DC-based nonprofit organization with more than 13,000 members who work in clinical research in more than 70 countries. ACRP’s vision is that clinical research is performed ethically, responsibly, and professionally everywhere in the world. ACRP’s mission is to promote excellence in clinical research. www.acrpnet.org

CONTACT:
Jovan Petty
+ 1.703.258.3520
media@acrpnet.org

New Agents and Innovative Therapy Program (NAIT) at Sick Kids :July newsletter and current list of open studies

The July 2016 NAIT newsletter can be found HERE.

WHAT’S NEW: IND 218 VITORI is now open at Sick Kids, as well as at BC Children’s, CHEO, and CHU Ste-Justine.

SickKids is one of only two centres in Canada offering MIBG therapy.
For more information, please visit: http://www.sickkids.ca/gfcc/mibg/index.htm

BOOKMARK NAIT:  The current list of all open trials can be found on the NAIT Website at https://www.sickkids.ca/HaematologyOncology/nait/index.html

HELPING FAMILIES NAVIGATE:  To assist patients and families with their transition, our Patient Navigator Program will collaborate with your team and the family to provide assistance with issues related to travel, accommodation, and navigating their way around the hospital and in the city. Furthermore, for patients living outside of Ontario, our Patient Navigator will assist physicians in completing an Out-of-Province Prior Approval Application to the Provincial Ministry of Health.

The vision of the New Agents and Innovative Therapy Program (NAIT) supports The Garron Cancer Centre and SickKids’ commitment to innovation and providing Canadian children and their families living with cancer with greater access to the best and newest treatment that will assist to improve clinical care.

See the active and upcoming studies available though the NAIT program at Sick Kids–April 2016 Newsletter


Find attached NAIT Newsletter April 2016, listing the clinical trials available through the Clinical Trials and New Agent and Innovative Therapy (NAIT) Program at SickKids.

A list of all active and upcoming studies available through NAIT can be found HERE.

The vision of the NAIT supports The Garron Cancer Centre and SickKids’ commitment to innovation and providing Canadian children and their families living with cancer with greater access to the best and newest treatment that will assist to improve clinical care and quality of life.

Information on the referral to Sick Kids and the Patient Navigator Program can be found HERE. The Patient Navigator Program provides assistance to you and collaborates with your primary team in locating appropriate resources both in your own community and in the Toronto area to assist in your travel and stay in Toronto.